NDC 72162-2001-01 - ACETAMINOPHEN AND CODEINE PHOSPHATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2001
- Requested NDC
- 72162-2001-01
- Package NDCs from labels
- 72162-2001-1, 72162-2001-5, 72162-2001-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-03-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN AND CODEINE PHOSPHATE - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-03-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2001-1 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 100 in 1 BOTTLE | TABLET | 100 | 103 | |
| 72162-2001-5 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 500 in 1 BOTTLE | TABLET | 500 | 103 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2001 | ACETAMINOPHEN AND CODEINE PHOSPHATE TABLET [BRYANT RANCH PREPACK] | 102 | Current NDC, 2 package rows | 20241017_879db1b5-6365-4151-9879-80d8a2a3cd8a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2001-1 | EA - Each | 72162-2001 | 37957eb9-eec4-46e4-a308-61d4df21ecc2 | 1 | 2023-12-05 |
| 72162-2001-5 | EA - Each | 72162-2001 | 1a45ea97-66ef-4ad8-a518-ee87187f41c6 | 1 | 2024-08-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Relief Acetaminophen PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Rite Aid Corporation | f77f0120-4042-4b11-ba9c-cd35e1cd0bee | 2026-01-05 | Warnings | 362O9ITL9D |
| Menstrual Relief Maximum Strength | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | United Natural Foods, Inc. dba UNFI | 807598ef-9f03-48df-b076-3ee95ef4b06c | 2026-01-05 | Warnings | 362O9ITL9D |
| Parathyropar | SYMPHYTUM OFFICINALE, BARYTA CARBONICA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, HEKLA LAVA, MANGANUM METALLICUM, PARATHYROID GLAND (BOVINE), RHUS TOX, SILICEA | Energique, Inc. | 6b098910-2f36-4757-a463-e01105340c43 | 2026-01-05 | Warnings | ETJ7Z6XBU4 |
| VACC HC | ANTIMONIUM TARTARICUM, ARSENICUM ALBUM, BRYONIA (ALBA), ECHINACEA (ANGUSTIFOLIA), GELSEMIUM SEMPERVIRENS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYOSCYAMUS NIGER, INFLUENZINUM, LEDUM PALUSTRE, MERCURIUS SOLUBILIS, MEZEREUM, NICOTINAMIDUM, HUMAN CORONAVIRUS (RNA), SENEGA OFFICINALIS, SILICEA, SPIGELIA ANTHELMIA, SULPHUR, THUJA OCCIDENTALIS, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 16d782b2-1bef-45e5-8a1d-721b1ffe5631 | 2026-01-05 | Warnings | ETJ7Z6XBU4 |
| Sinus Pressure and Pain PE Maximum Strength | ACETAMINOPHEN AND PHENYLEPHRINE HCL | Rite Aid Corporation | 347868e4-0182-4e16-895c-ec269895c57c | 2026-01-02 | Warnings | 362O9ITL9D |
| Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | Hikma Pharmaceuticals USA Inc. | 6e0e8abc-512b-42f7-8323-434c589edecf | 2026-01-02 | Boxed warning, Warnings, Adverse reactions | GSL05Y1MN6 362O9ITL9D |
| Pain Relief Extra Strength, Non-Aspirin | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | 1fb5e871-45fd-46fe-bf73-5192f8316e8e | 2026-01-02 | Warnings | 362O9ITL9D |
| Severe Sinus Pain and Congestion Daytime | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | CVS Pharmacy | 4af347ce-9745-4a5e-8ce9-e7c97a0a6cc7 | 2026-01-02 | Warnings | 362O9ITL9D |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Valu Merchandisers Company | 0005aafa-08f8-4990-a54d-cc097195708f | 2026-01-02 | Warnings | 362O9ITL9D |
| Extra Strength Pain Reliever | ACETAMINOPHEN | Walmart Inc. | 152bb455-da5b-ae13-e063-6394a90acab0 | 2026-01-01 | Warnings | 362O9ITL9D |
| Dr. Cocoa for Children Pain and Fever | ACETAMINOPHEN | Infirst Healthcare Inc. | 486ea294-6d18-a907-e063-6294a90ad284 | 2026-01-01 | Warnings | 362O9ITL9D |
| Tramadol Hydrochloride and Acetaminophen | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | Amneal Pharmaceuticals of New York LLC | d51600e2-2f73-483c-9b2e-f142bafff16d | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| PANCOLD A | ACETAMINOPHEN, GUAIFENESIN, PENTOXYVERINE CITRATE, PHENYLPEHRINE HYDCROCHLORIDE, CHLORPHENIRAMINE MALEATE, CAFFEINE ANHYDROUS | DONGWHA PHARM. CO. LTD. | fc8f1807-d344-ccc2-e053-6294a90a5089 | 2025-12-31 | Warnings | 362O9ITL9D |
| ED APAP | ACETAMINOPHEN | EDWARDS PHARMACEUTICALS, INC. | f76d5fff-ebea-40f9-aad3-4064a0c863f0 | 2025-12-31 | Warnings | 362O9ITL9D |
| EXTRA STRENGTH PAIN RELIEF | ACETAMINOPHEN | GERI-CARE PHARMACEUTICAL CORP | 99ec63ef-aa28-c2fb-e053-2a95a90a9f6d | 2025-12-31 | Warnings | 362O9ITL9D |
| Geri Care Tussin CF Max | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN | GERI-CARE PHARMACEUTICAL CORP | 4744669c-7f33-e35f-e063-6394a90a79b7 | 2025-12-31 | Warnings | 362O9ITL9D |
| Puregen Labs Acetaminophen | ACETAMINOPHEN | Advanced Rx LLC | 474580af-f6b0-e440-e063-6394a90aaada | 2025-12-31 | Warnings | 362O9ITL9D |
| Dologesic NF | ACETAMINOPHEN, DEXBROMPHENIRAMINE MALEATE | Llorens Pharmaceutical International Division | 974fc0d5-7a99-46fb-af38-b91240f728fa | 2025-12-31 | Warnings | 362O9ITL9D |
| Dologesic DF | ACETAMINOPHEN, DEXBROMPHENIRAMINE MALEATE | Llorens Pharmaceutical International Division | 55768b45-fd98-4779-85b6-6a50c628677e | 2025-12-31 | Warnings | 362O9ITL9D |
| Liquid Acetaminophen | ACETAMINOPHEN | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | a7dbd4c0-53eb-4368-917b-1432c09ce6b4 | 2025-12-31 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.